Introduction

Innovation is at the heart of what we do

AstraZeneca is a global, biopharmaceutical company with research and development at its core.

LabTalk is AstraZeneca’s new science-focused blog where you can hear from scientists, researchers and academics discussing novel ideas, research and innovation.

18 June 2013

Drug repurposing research launched via NIH, pharma & academia

Cambridge plans 2 THM 18 June 2013

Cambridge: An innovation hub for life sciences

Oncology goldenTHM 3 June 2013

Identifying new treatment options for Hairy Cell Leukemia

Pan-European drug discovery platform launched

CRL_PartnershipThe European Lead Factory, a novel platform for innovative drug discovery, was recently launched by an international consortium of 30 partners, including AstraZeneca.

Find out more about Open Innovation on LabTalk
Read the press release

CytImmune collaboration into nanomedince for cancer treatment

ScientistTesttube100x200CytImmune and AstraZeneca entered into an agreement in December to study the feasibility of a new cancer nanomedicine that will bind an oncology compound from AstraZeneca to CytImmune’s CYT-6091 nanomedicine platform.

Find out more on LabTalk
Read the press release

Scrip Roundtable: Preventing a Pre-antibiotic Future

ScripIn June, AstraZeneca took part in a moderated roundtable discussion exploring the increasing resistance of bacteria and the research and use of antibiotics.

Watch the discussion in full
Watch the highlights video